He Left MIT At 22 To Solve A Problem Investors Didn’t Get. Now His Company Is Worth $6 Billion#Biology#Research#Software#Entrepreneurism#Biotech·forbes.com·Mar 22, 2022He Left MIT At 22 To Solve A Problem Investors Didn’t Get. Now His Company Is Worth $6 Billion
Gene Therapy Restored Vision To Patient Who Hadn’t Seen Colors in Years#Genetic Engineering#Biology#Biotech·futurism.com·Sep 29, 2021Gene Therapy Restored Vision To Patient Who Hadn’t Seen Colors in Years